LCID Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction ALT Q1 2026 Earnings Narrowed Loss and EPS Beat Signal Progress in Metabolic Pipeline AMGN Q1 2026 Earnings EPS Surpasses Estimates by 614 Stock Edges Higher CALC Q1 2026 Earnings Surprising Profit on a PerShare Basis Yet Shares Decline Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues LBRDK Q3 2025 Earnings Strong EPS Beat Fueled by Investment Gains Stock Edges Lower